s6y
Company name or ticker
Search
BridgeBio Oncology Therapeutics, Inc.
424B4
Prospectus filed pursuant to Rule 424(b)(4)
Filed
Tuesday, February 13, 2024
Accession number
0001213900-24-012731
Documents
PROSPECTUS
424B4
On sec.gov
Filing index
All files
Complete submission text
SGML header